Clarence Hale

4.3k total citations · 1 hit paper
41 papers, 2.4k citations indexed

About

Clarence Hale is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Clarence Hale has authored 41 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Surgery. Recurrent topics in Clarence Hale's work include Hormonal Regulation and Hypertension (10 papers), Regulation of Appetite and Obesity (6 papers) and Biochemical Analysis and Sensing Techniques (6 papers). Clarence Hale is often cited by papers focused on Hormonal Regulation and Hypertension (10 papers), Regulation of Appetite and Obesity (6 papers) and Biochemical Analysis and Sensing Techniques (6 papers). Clarence Hale collaborates with scholars based in United States, United Kingdom and Sweden. Clarence Hale's co-authors include Murielle M. Véniant, Shanaka Stanislaus, Michelle Chen, Jing Xu, David J. Lloyd, Steven Vonderfecht, Glenn Sivits, Randy Hecht, Jason K. Kim and Yue‐Sheng Li and has published in prestigious journals such as Nature, PLoS ONE and Biochemistry.

In The Last Decade

Clarence Hale

40 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice

2008 974 citations Jing Xu, David J. Lloyd et al. profile →

Peers

Countries citing papers authored by Clarence Hale

Since Specialization

Citations

This map shows the geographic impact of Clarence Hale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clarence Hale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clarence Hale more than expected).

Fields of papers citing papers by Clarence Hale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clarence Hale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clarence Hale. The network helps show where Clarence Hale may publish in the future.

Co-authorship network of co-authors of Clarence Hale

This figure shows the co-authorship network connecting the top 25 collaborators of Clarence Hale. A scholar is included among the top collaborators of Clarence Hale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clarence Hale. Clarence Hale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15 2020 ·PLoS ONE ·Marina Stolina, Xin Luo, Denise Dwyer, Chun-Ya Han, (unknown), Ying Zhang, Yumei Xiong, Yinhong Chen, Jun Yin, Artem Shkumatov, Brandon Ason, Clarence Hale, Murielle M. Véniant	13
2	Molecular targeting of the GK-GKRP pathway in diabetes 2014 ·Expert Opinion on Therapeutic Targets ·Clarence Hale, David J. Lloyd, Andrea Pellacani, Murielle M. Véniant	16
3	Discovery of Small-Molecule Glucokinase Regulatory Protein Modulators That Restore Glucokinase Activity 2014 ·SLAS DISCOVERY ·Kui Chen, Klaus Michelsen, Robert J. Kurzeja, (unknown), (unknown), David J. St. Jean, Clarence Hale, Robert C. Wahl	5
4	FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice 2012 ·PLoS ONE ·Murielle M. Véniant, Clarence Hale, Joan Helmering, Michelle Chen, Shanaka Stanislaus, (unknown), Steven Vonderfecht, Jing Xu, David J. Lloyd	124
5	A Volumetric Method for Quantifying Atherosclerosis in Mice by Using MicroCT: Comparison to En Face 2011 ·PLoS ONE ·David J. Lloyd, Joan Helmering, Stephen A. Kaufman, James R. Turk, Matthew J. Silva, (unknown), David M. Weinstein, (unknown), Clarence Hale, Murielle M. Véniant	20
6	Antidiabetic effects of 11β‐HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis 2009 ·Diabetes Obesity and Metabolism ·David J. Lloyd, Joan Helmering, David Cordover, (unknown), (unknown), Clarence Hale, (unknown), Mingyue Zhou, (unknown), Stephen A. Kaufman, Murielle M. Véniant	28
7	Time of the day for 11β‐HSD1 inhibition plays a role in improving glucose homeostasis in DIO mice 2008 ·Diabetes Obesity and Metabolism ·Murielle M. Véniant, Clarence Hale, Renée Komorowski, (unknown), David J. St. Jean, Christopher Fotsch, (unknown)	22
8	Determination of prednisolone in human adipose tissue incubation medium using LC–MS/MS to support the measurement of 11β-hydroxysteroid dehydrogenase activity☆ 2008 ·Journal of Chromatography B ·(unknown), Mark J. Rose, Ian McCaffery, (unknown), (unknown), Clarence Hale, Maurice G. Emery, Christopher James	6
9	High Capacity Homogeneous Non-Radioactive Cortisol Detection Assays for Human 11 β -Hydroxysteroid Dehydrogenase Type 1 2007 ·Assay and Drug Development Technologies ·Violeta Yu, Yanyan Tudor, Clarence Hale, Matthew Plant, Ki Won Kim, Minghan Wang, (unknown), Tisha San Miguel, Michelle Chen, (unknown), (unknown), Robert J. Kurzeja, (unknown)	1
10	Structural Characterization and Pharmacodynamic Effects of an Orally Active 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitor 2007 ·Chemical Biology & Drug Design ·Clarence Hale, Murielle M. Véniant, Zhulun Wang, Michelle Chen, (unknown), Rod Cupples, Dean Hickman, Xiaoshan Min, Athena Sudom, Haoda Xu, (unknown), Christopher Fotsch, David J. St. Jean, Minghan Wang	26
11	The selectivity of tyrosine 280 of human 11β‐hydroxysteroid dehydrogenase type 1 in inhibitor binding 2007 ·FEBS Letters ·Ki Won Kim, Zhulun Wang, (unknown), Trace S. Tsuruda, Michelle Chen, Clarence Hale, (unknown), Stefan Svensson, (unknown), Fei Xiong, Minghan Wang	4
12	A High-Throughput Microfluidic Assay for SH2 Domain-Containing Inositol 5-Phosphatase 2 2006 ·Assay and Drug Development Technologies ·(unknown), Clarence Hale, Aileen J. Zhou, Robert J. Kurzeja, (unknown), (unknown), Minghan Wang, John D. McCarter	11
13	The role of tyrosine 177 in human 11β-hydroxysteroid dehydrogenase type 1 in substrate and inhibitor binding: an unlikely hydrogen bond donor for the substrate 2006 ·Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Ki Won Kim, Zhulun Wang, (unknown), Trace S. Tsuruda, Michelle Chen, Clarence Hale, (unknown), Stefan Svensson, (unknown), Fei Xiong, Minghan Wang	15
14	Solid-phase synthesis and structure–activity relationships of novel biarylethers as melanin-concentrating hormone receptor-1 antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Vu Ma, Anthony W. Bannon, (unknown), Clarence Hale, Faye Hsieh, Christopher Hulme, (unknown), John Salon, Carlo van Staden, Paul Tempest	4
15	Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides 2005 ·Bioorganic & Medicinal Chemistry Letters ·Christopher Fotsch, Nianhe Han, (unknown), Yunxin Bo, (unknown), Ning Chen, James Davis, (unknown), Clarence Hale, (unknown), Michael Kelly, Qingyian Liu, Mark H. Norman, D.M. Smith, Markian M. Stec, Nuria Tamayo, Ning Xi, Shimin Xu, Anthony W. Bannon, James W. Baumgartner	16
16	Design of a new peptidomimetic agonist for the melanocortin receptors based on the solution structure of the peptide ligand, Ac-Nle-cyclo[Asp-Pro-dPhe-Arg-Trp-Lys]-NH2 2003 ·Bioorganic & Medicinal Chemistry Letters ·Christopher Fotsch, D.M. Smith, Jeffrey A. Adams, Janet Cheetham, (unknown), Elizabeth M. Doherty, Clarence Hale, Mark A. Jarosinski, Michael Kelly, Mark H. Norman, Nuria Tamayo, Ning Xi, James W. Baumgartner	37
17	Synthesis of novel melanocortin 4 receptor agonists and antagonists containing a succinamide core 2003 ·Bioorganic & Medicinal Chemistry Letters ·Ning Xi, Clarence Hale, Michael Kelly, Mark H. Norman, Markian M. Stec, Shimin Xu, James W. Baumgartner, Christopher Fotsch	26
18	Synthesis and Structure−Activity Relationships of Trisubstituted Phenyl Urea Derivatives as Neuropeptide Y5 Receptor Antagonists 2001 ·Journal of Medicinal Chemistry ·Christopher Fotsch, (unknown), Ning Chen, Clarence Hale, (unknown), Mark H. Norman	35
19	Hydrophilic Penicillins produced by Penicillium chrysogenum 1953 ·Nature ·Clarence Hale, G. A. MILLER, (unknown)	4
20	Culture Media for Large-scale Production of Micrococcin 1952 ·Journal of General Microbiology ·(unknown), G. A. MILLER, Clarence Hale	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact